Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides a Corporate Update

NEXT STORY
Study Highlights Potential Clinical Value of ePlex® Blood Culture ID Panels
PREV STORY
Kronos Advanced Technologies Announces SARS-CoV-2 Test Results for Its Line of Air Purifiers
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Checkpoint Therapeutics to Present at the Jefferies 2017 Global Healthcare Conference

NEW YORK, June 01, 2017 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (OTCQX:CKPT), a ...

author_avatar
NASDAQ Market News

Apellis and Sobi Receive Positive CHMP Opinion for Aspaveli® (pegcetacoplan) for the Treatment of PNH

author_avatar
NASDAQ Market News

Cytokinetics Announces Presentation of Data From Phase 2 Clinical Study of Reldesemtiv in Patients With Spinal Muscular Atrophy at the 2018 Annual Cure SMA Conference

author_avatar
NASDAQ Market News